CIK 0001661053
- Non-accelerated filer
- Smaller reporting company
enVVeno Medical Corp
Sign in to watch- Ticker
- NVNO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330936180
- Phone
- +1 949-261-2900
- Business address
- 70 DOPPLER, IRVINE, CA, 92618
- Former names
- Hancock Jaffe Laboratories, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $123
- in 1 filing, $123 under 10b5-1 plans
Net −$123. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-11 | Jenusaitis Matthew Director | Grant or award · Stock Options | +135,883 | 135,883 | ||
| 2024-12-19 | Jenusaitis Matthew Director | Purchase | +9,620 | $2.53 | $24K | 16,545 |
| 2024-12-18 | Jenusaitis Matthew Director | Grant or award · Stock Options | +19,752 | 19,752 | ||
| 2023-12-05 | Jenusaitis Matthew Director | Grant or award · Stock Options | +13,856 | 13,856 | ||
| 2022-11-30 | Jenusaitis Matthew Director | Grant or award · Stock Options | +8,403 | 8,403 | ||
| 2022-09-13 | Jenusaitis Matthew Director | Exercise or conversion | +1,041 | 6,925 | ||
| 2022-09-13 | Jenusaitis Matthew Director | Exercise or conversion · Restricted Stock Units | −1,041 | 0 | ||
| 2021-11-30 | Jenusaitis Matthew Director | Grant or award · Stock Options | +7,211 | 7,211 | ||
| 2021-09-13 | Jenusaitis Matthew Director | Exercise or conversion | +1,042 | 5,884 | ||
| 2021-09-13 | Jenusaitis Matthew Director | Exercise or conversion · Restricted Stock Units | −1,042 | 2,084 | ||
| 2021-08-25 | Jenusaitis Matthew Director | Purchase | +1,300 | $7.70 | $10K | 4,842 |
| 2021-02-18 | Jenusaitis Matthew Director | Grant or award · Stock Option | +5,673 | 5,673 | ||
| 2020-07-18 | Jenusaitis Matthew Director | Grant or award | +62,500 | 62,500 | ||
| 2020-07-18 | Jenusaitis Matthew Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-09-13 | Jenusaitis Matthew Director | Grant or award · Restricted Stock Units | +78,125 | 78,125 | ||
| 2019-09-13 | Jenusaitis Matthew Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 |
Page 1 of 1 · 16 trades